The presented results showed that the proinflammatory marker IL-6 stimulates the expression of S100A4 and S100A8 proteins in CLL, mediated by JAK1/2- and NF-κB-signaling. This evidence concerns the gene JAK1 and B-cell chronic lymphocytic leukemia.